Cumberland Pharmaceuticals Inc.

NasdaqGS:CPIX Rapporto sulle azioni

Cap. di mercato: US$14.9m

Cumberland Pharmaceuticals Gestione

Gestione criteri di controllo 3/4

Cumberland Pharmaceuticals Il CEO è A. Kazimi, nominato in Jan1999, e ha un mandato di 25.83 anni. la retribuzione annua totale è $ 1.17M, composta da 57.7% di stipendio e 42.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 40.59% delle azioni della società, per un valore di $ 6.04M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.9 anni e 11.5 anni.

Informazioni chiave

A. Kazimi

Amministratore delegato

US$1.2m

Compenso totale

Percentuale dello stipendio del CEO57.7%
Mandato del CEO25.8yrs
Proprietà del CEO40.6%
Durata media del management6.9yrs
Durata media del Consiglio di amministrazione11.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Nov 04
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Mar 07
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Prospects Need A Boost To Lift Shares

Jan 09
Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Prospects Need A Boost To Lift Shares

Why Investors Shouldn't Be Surprised By Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S

Oct 02
Why Investors Shouldn't Be Surprised By Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Aug 10
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?

Mar 18
Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet?

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Nov 02
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Calculating The Fair Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)

Jul 20
Calculating The Fair Value Of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Apr 15
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt?

Checking In On Cumberland Pharmaceuticals

Jan 04

Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?

Nov 09
Health Check: How Prudently Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Use Debt?

We Think Some Shareholders May Hesitate To Increase Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Compensation

Apr 21
We Think Some Shareholders May Hesitate To Increase Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Compensation

Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way?

Feb 13
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Debt In A Risky Way?

One Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Analyst Just Cut Their EPS Forecasts

Nov 19
One Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Analyst Just Cut Their EPS Forecasts

Cumberland Pharmaceuticals Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 11

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di A. Kazimi rispetto agli utili di Cumberland Pharmaceuticals?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$11m

Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$1mUS$675k

-US$6m

Sep 30 2023n/an/a

-US$2m

Jun 30 2023n/an/a

-US$2m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022US$1mUS$635k

-US$6m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$7m

Dec 31 2021US$1mUS$610k

-US$6m

Sep 30 2021n/an/a

-US$3m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$1mUS$590k

-US$7m

Sep 30 2020n/an/a

-US$8m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$10m

Dec 31 2019US$1mUS$567k

-US$9m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$1mUS$545k

-US$11m

Sep 30 2018n/an/a

-US$6m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$1mUS$523k

-US$8m

Compensazione vs Mercato: La retribuzione totale di A. ($USD 1.17M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 646.00K ).

Compensazione vs guadagni: La retribuzione di A. è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

A. Kazimi (66 yo)

25.8yrs

Mandato

US$1,169,530

Compensazione

Mr. A. J. Kazimi, MBA, founded Cumberland Pharmaceuticals Inc. in 1999 and has been its Chairman and Chief Executive Officer since 1999. Mr. Kazimi serves as the President of Cumberland Pharmaceuticals Inc...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
A. Kazimi
Founder25.8yrsUS$1.17m40.59%
$ 6.0m
John Hamm
VP & CFO3.5yrsUS$282.32k0.19%
$ 27.6k
James Herman
Executive VP of National Accounts & Chief Compliance Officer8.1yrsUS$400.15k0.27%
$ 40.6k
Chris Bitterman
Vice President of Sales & Marketingno dataUS$316.29k0.033%
$ 5.0k
Todd Anthony
Vice President of Organizational Developmentno dataUS$330.85k0.12%
$ 17.3k
Jean Marstiller
Senior VP of Administrative Services & Corporate Secretaryno dataUS$298.01kNessun dato
Adam Mostafa
Managing Director5.8yrsNessun datoNessun dato
Erin Gull
Senior Corporate Relations Associateno dataNessun datoNessun dato

6.9yrs

Durata media

66yo

Età media

Gestione esperta: Il team dirigenziale di CPIX è esperto e expertise (durata media dell'incarico 6.9 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
A. Kazimi
Founder25.8yrsUS$1.17m40.59%
$ 6.0m
Joseph Williams
Member of Pharmaceutical Advisory Boardno dataNessun datoNessun dato
Joseph Galante
Independent Director6.2yrsUS$61.20k0.42%
$ 62.9k
Robert Roberts
Member of Medical Advisory Boardno dataNessun datoNessun dato
Gordon Bernard
Chairman of Medical Advisory Board & Independent Director14.8yrsUS$98.00kNessun dato
J. Hix
Member of Pharmaceutical Advisory Boardno dataUS$233.65kNessun dato
Martin Brown
Director2.3yrsUS$50.00k0.043%
$ 6.4k
David Warrell
Member of Medical Advisory Boardno dataNessun datoNessun dato
Timothy Meakin
Member of Pharmaceutical Advisory Boardno dataNessun datoNessun dato
Ben deBoisblanc
Member of Medical Advisory Boardno dataNessun datoNessun dato
Caroline Young
Independent Director8.2yrsUS$61.20k0.21%
$ 30.8k
James Jones
Independent Director14.8yrsUS$60.20kNessun dato

11.5yrs

Durata media

72yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di CPIX è composto da personale esperto e esperto (durata media dell'incarico 11.5 anni).